Interacting Drugs |
Rivaroxaban vs Collagenase (Systemic) |
Security Level |
 |
Mechanism |
Collagenase (Systemic): Anticoagulants may enhance the adverse/toxic effect of Collagenase (Systemic). Specifically, the risk of injection site bruising and/or bleeding may be increased. |
Management |
Monitor therapy |
Rivaroxaban vs Collagenase (Systemic)
Post Review about Rivaroxaban vs Collagenase (Systemic) Click here to cancel reply.
Other Interactions of Rivaroxaban
Other Interactions of Collagenase (Systemic)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.